Oesophageal Chemoradiotherapy in the UK-Current Practice and Future Directions

Oesophageal Chemoradiotherapy in the UK-Current Practice and Future Directions

Show other versions (1)

The SCOPE 1 trial closed to recruitment in early 2012 and has demonstrably improved the quality of UK radiotherapy. It has also shown that there is an enthusiastic upper gastrointestinal clinical oncology community that can successfully complete trials and deliver high-quality radiotherapy. Followin...

Full description

Bibliographic Details
Main Authors:	Gwynne, S, Falk, S, Gollins, S, Wills, L, Bateman, A, Cummins, S, Grabsch, H, Hawkins, M, Maggs, R, Mukherjee, S, Radhakrishna, G, Roy, R, Sharma, R, Spezi, E, Crosby, T
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Oesophageal Chemoradiotherapy in the UK--current practice and future directions.
by: Gwynne, S, et al.
Published: (2013)

NeoSCOPE RTTQA: pre-accrual and on-trial review of all patients in a UK oesophageal RT trial
by: Evans, E, et al.
Published: (2018)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
by: Mukherjee, S, et al.
Published: (2017)

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.
by: Crosby, T, et al.
Published: (2013)

4DCT oesophageal tumour delineation in SCOPE2 – how is radiotherapy quality assurance beneficial?
by: Cox, S, et al.
Published: (2018)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
by: Mukherjee, S, et al.
Published: (2015)

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
by: Mukherjee, S, et al.
Published: (2015)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
by: Warren, S, et al.
Published: (2016)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
by: Crosby, T, et al.
Published: (2017)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation
by: Carrington, R, et al.
Published: (2015)

The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial
by: Carrington, E, et al.
Published: (2016)

Effect of anaemia prevention on survival and local control in oesophageal cancers treated with chemoradiotherapy.
by: Tuan, J, et al.
Published: (2012)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
by: Mukherjee, S, et al.
Published: (2013)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
by: Rana, M, et al.
Published: (2021)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
by: Holyoake, D, et al.
Published: (2016)

A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network.
by: Adams, R, et al.
Published: (2007)

Chemoradiotherapy for carcinoma of the oesophagus: Experience of a single institution
by: Toy, E, et al.
Published: (2001)

Oesophageal and gastro-oesophageal junction tumours
by: Bird-Lieberman, E, et al.
Published: (2007)

Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy
by: Holyoake, D, et al.
Published: (2017)

Small cell oesophageal carcinoma: an institutional experience and review of the literature.
by: Hudson, E, et al.
Published: (2007)

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
by: Holyoake, DLP, et al.
Published: (2018)

Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer
by: Foley, KG, et al.
Published: (2017)

An analysis of plan robustness for oesophageal tumours: comparing volumetric modulated arctherapy plans and spot scanning proton planning
by: Warren, S, et al.
Published: (2016)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
by: Mukherjee, S, et al.
Published: (2024)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
by: Crosby, T, et al.
Published: (2004)

Normal tissue sparing with respiratory adapted volumetric modulated arc therapy for distal oesophageal and gastro-oesophageal tumours.
by: Hafeez, S, et al.
Published: (2014)

Correlation of 18F-fluorodeoxyglucose positron emission tomography parameters with patterns of disease progression in locally advanced pancreatic cancer after definitive chemoradiotherapy
by: Wilson, J, et al.
Published: (2017)

Oesophageal complications in epidermolysis bullosa
by: Travis, S, et al.
Published: (1991)

Patterns of recurrence after definitive chemo-radiotherapy for oesophageal carcinoma
by: Button, MR, et al.
Published: (2007)

Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
by: Lafarge, MW, et al.
Published: (2024)

Modern management of oesophageal varices.
by: Gow, P, et al.
Published: (2001)

Delayed surgical intervention after chemoradiotherapy in esophageal cancer
by: Chidambaram, S, et al.
Published: (2023)

Early diagnosis of oesophageal cancer.
by: Bird-Lieberman, E, et al.
Published: (2009)

Barrett's oesophagus and oesophageal adenocarcinoma
by: Bird-Lieberman, E, et al.
Published: (2011)

Rectal adenocarcinoma with oncocytic features: possible relationship with preoperative chemoradiotherapy.
by: Rouzbahman, M, et al.
Published: (2006)

Abnormalities of chromosome 17 in oesophageal cancer.
by: Moodley, R, et al.
Published: (2007)

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
by: Borghesi, S, et al.
Published: (2008)

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
by: Borghesi, S, et al.
Published: (2008)

Modelling normal tissue toxicity in pancreatic chemoradiotherapy
by: Witztum, A
Published: (2018)

Volumetric modulated arc therapy planning for distal oesophageal malignancies.
by: Hawkins, M, et al.
Published: (2012)